Barinthus Biotherapeutics (BRNS) Net Income Growth (3y) (2023 - 2026)
Barinthus Biotherapeutics (BRNS) Net Income Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 84.25% |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 32.96% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 30.59% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -46.86% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 19.97% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 13.80% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.57 Mn | -39.54 Mn | - | 32.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.78% |
| Dec 31, 2025 | 19.35% |
| Sep 30, 2025 | -55.67% |
| Jun 30, 2025 | -49.58% |
| Mar 31, 2025 | -112.81% |
| Dec 31, 2024 | -7.19% |
| Sep 30, 2024 | -13.71% |
| Jun 30, 2024 | -0.17% |
| Mar 31, 2024 | -21.03% |
| Dec 31, 2023 | -12.13% |
| Sep 30, 2023 | -80.56% |
| Jun 30, 2023 | -76.46% |
| Mar 31, 2023 | -57.67% |